IMARC Group has recently released a new research study titled “Mexico Laboratory Centrifuge Market Size, Share, Trends and Forecast by Product Type, Model Type, Rotor Design, Intended Use, Application, End-User, and Region, 2026-2034”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.

Market Overview

The Mexico laboratory centrifuge market size was valued at USD 22.3 Million in 2025 and is projected to reach USD 31.3 Million by 2034, growing at a CAGR of 3.82% during 2026–2034. The market is driven by expanding healthcare infrastructure, rising pharmaceutical manufacturing investments, and increasing demand for advanced diagnostic capabilities. Government initiatives and biotechnology sector growth support adoption of high-performance centrifugation technologies across hospitals, research institutions, and pharmaceutical companies.

Study Assumption Years

• Base Year: 2025

• Historical Year/Period: 2020-2025

• Forecast Year/Period: 2026-2034

Mexico Laboratory Centrifuge Market Key Takeaways

• Current Market Size: USD 22.3 Million in 2025

• CAGR: 3.82% from 2026 to 2034

• Forecast Period: 2026-2034

• Equipment dominates the product type segment with 57.62% market share in 2025 due to its essential role in clinical diagnostics, pharmaceutical research, and biomanufacturing.

• Benchtop centrifuges lead the model type segment with 71.24% market share in 2025 owing to their compact design and affordability.

• Fixed-angle rotors hold the largest rotor design segment share at 36.56% in 2025, favored for efficiency and faster sedimentation.

• General purpose centrifuges lead the intended use segment with 46.63% market share in 2025, valued for their versatility across various laboratory applications.

• The market is supported by government and private investments in healthcare infrastructure, pharmaceutical manufacturing, and research facilities.

Sample Request Link: https://www.imarcgroup.com/mexico-laboratory-centrifuge-market/requestsample

Mexico Laboratory Centrifuge Market Growth Factors

The expansion of pharmaceutical manufacturing and investments is a significant driver of the Mexico laboratory centrifuge market. Mexico's pharmaceutical industry is experiencing considerable capital investments from domestic and international companies to enhance manufacturing capabilities. Government initiatives promoting pharmaceutical sovereignty and reducing foreign drug reliance have attracted over 13 Billion pesos from companies like Kener, Genbio, Neolpharma, and Neolsym in July 2025 to broaden drug development and manufacturing. These investments increase demand for laboratory centrifuge equipment essential in quality control and research.

Growing healthcare infrastructure and diagnostic capabilities further stimulate market growth. Mexico's modernization efforts include expanding hospitals, clinical laboratories, and diagnostic centers across urban and regional locations. Government preventive healthcare programs and early disease detection initiatives, such as IMSS Bienestar's La Muestra Viaja launched in March 2025, enhance diagnostic access. This infrastructure expansion directly supports adopting centrifuge technology in multiple healthcare settings throughout the country.

The rising prevalence of chronic ailments increases diagnostic testing demand in Mexico, boosting centrifuge equipment needs. Conditions like diabetes, cardiovascular diseases, and cancer require ongoing monitoring through blood tests prepared with centrifuges. With 85,855,300 people affected by diabetes in 2024, continuous glucose monitoring and diagnostics drive equipment investments. The demographic shift towards an aging population and improved insurance coverage further sustains laboratory equipment procurement to manage chronic disease care effectively.

Mexico Laboratory Centrifuge Market Segmentation

Breakup By Product Type

• Equipment

• Accessories

Equipment dominates with a 57.62% market share in 2025 due to its essential role in diagnostics, manufacturing, and research. Rising demand for specialized centrifuges like ultracentrifuges and microcentrifuges supports segment growth, aided by government initiatives for pharmaceutical sovereignty.

Breakup By Model Type

• Benchtop Centrifuges

• Floor-Standing Centrifuges

Benchtop centrifuges lead with 71.24% share in 2025, favored for compactness, cost-effectiveness, and suitability for routine procedures in space-constrained clinical and research laboratories.

Breakup By Rotor Design

• Fixed-Angle Rotors

• Swinging-Bucket Rotors

• Vertical Rotors

• Others

Fixed-angle rotors hold 36.56% market share in 2025, favored for efficiency in high-throughput and rapid sedimentation, enabling consistent results in clinical labs.

Breakup By Intended Use

• General Purpose Centrifuges

• Clinical Centrifuges

• Preclinical Centrifuges

General purpose centrifuges represent 46.63% market share in 2025, valued for flexibility to perform diverse blood separation and research tasks across Mexican laboratories.

Breakup By Application

• Diagnostics

• Microbiology

• Cellomics

• Genomics

• Proteomics

• Blood Component Separation

• Others

Diagnostics segment is significant due to high routine clinical testing volumes in hospitals and labs, with centrifuges critical for blood and urine sample separation supporting multiple tests.

Breakup By End-User

• Hospitals

• Biotechnology and Pharmaceutical Companies

• Academic and Research Institutions

Hospitals dominate as end-users due to large daily diagnostic volumes requiring reliable centrifuges; biotechnology firms demand advanced models for drug development; research institutions use centrifuges for life science studies.

Breakup By Region

• Northern Mexico

• Central Mexico

• Southern Mexico

• Others

Regional Insights

Northern Mexico holds a prominent share of the laboratory centrifuge market, supported by its developed industrial base, proximity to the United States, and concentration of private hospitals and diagnostic labs. This region benefits from technology transfer and growing pharmaceutical manufacturing and medical research activities that stimulate demand for efficient centrifuges in clinical and industrial settings.

Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=32414&flag=C

Key Players

• Kener

• Genbio

• Neolpharma

• Neolsym

Recent Developments & News

In July 2025, four Mexican pharmaceutical companies—Kener, Genbio, Neolpharma, and Neolsym— announced investment plans exceeding 13 Billion pesos to expand drug development and manufacturing capabilities. Additionally, during January to September 2024, Mexico’s pharmaceutical sector attracted USD 784 Million in foreign direct investment, reinforcing manufacturing and research capacities. In March 2025, IMSS Bienestar launched "La Muestra Viaja," an initiative to provide laboratory tests to uninsured individuals, reducing diagnostic costs and wait times by forwarding samples to expert labs.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201971-6302